[Plasma heparin precipitate as a source of fibronectin in the treatment of patients with trophic skin lesions].
A study with the help of the hard phase enzyme immunoassay has shown that during incubation in the cold of fresh and fresh-frozen donor plasma in the presence of 10 I. U./ml-30 I.U./ml of heparin over 80% of fibronectin with relation to its basal level in the same plasma sample passes to the residue (heparin precipitate). The effectiveness of local use of the preparation of plasmic heparin precipitate (fibronectin concentration of 1 to 1.5 mg/ml) for therapy of patients with heavy trophic skin lesions was substantiated.
D005353:Fibronectins / Q000627:therapeutic use*; D006493:Heparin / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D012883:Skin Ulcer / Q000188:drug therapy*
D005353:Fibronectins; D006493:Heparin
Plazmennyĭ geparinovyĭ pretsipitat kak istochnik fibronektina dlia lecheniia bol'nykh s troficheskimi porazheniiami kozhi.